Left ventricular shape predicts different types of cardiovascular events in the general population

Bharath Ambale-Venkatesh1, Kihei Yoneyama1, Ravi K Sharma1

  • 1Johns Hopkins University, Baltimore, Maryland, USA.

Insights

Sphericity volume index (SVI) predicts cardiovascular events. Low SVI indicates risk for coronary heart disease and heart failure, while extreme SVI predicts heart failure and atrial fibrillation.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Public Health

Background:

  • Left ventricular (LV) remodelling is a key factor in cardiovascular disease.
  • Sphericity volume index (SVI) is a novel indicator of LV remodelling.
  • Assessing SVI's predictive capability for cardiovascular events is crucial for risk stratification.

Purpose of the Study:

  • To determine if SVI predicts incident cardiovascular events over 10 years.
  • To investigate SVI's association with coronary heart disease (CHD), cardiovascular disease (CVD), heart failure (HF), and atrial fibrillation (AF).
  • To evaluate SVI's role in a multiethnic population.

Main Methods:

  • Utilized magnetic resonance imaging (MRI) data from 5004 participants in the Multi-Ethnic Study of Atherosclerosis (MESA).
  • Calculated SVI based on LV volume and dimensions from cine MRI.
  • Employed Cox regression to assess SVI's predictive performance for incident outcomes over a 10-year follow-up.

Main Results:

  • Low sphericity at end-diastole predicted incident CHD and CVD.
  • Both low and high sphericity at end-systole predicted incident HF.
  • High sphericity also predicted incident AF.
  • Low sphericity correlated with higher CVD risk factors.

Conclusions:

  • Lowest sphericity predicts incident CHD, CVD, and HF in a multiethnic population.
  • Extreme sphericity (both low and high) strongly predicts incident HF and AF.
  • SVI improved risk prediction models specifically for HF, but not for overall CVD or CHD.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
566
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
520
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
748
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
838